EXCLI J EXCLI Journal 1611-2156 Leibniz Research Centre for Working Environment and Human Factors 2018-2021 Doc8 Editorial material Highlight report: Role of the ATP-releasing Panx channels in liver fibrosis González Leiva Daniela Fernanda * 1 IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund, GERMANY *To whom correspondence should be addressed: Daniela Fernanda González Leiva, IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund, GERMANY, E-mail: gonzalez@ifado.de 22 01 2019 2019 18 8 9 17 12 2018 28 12 2018 Copyright © 2019 González Leiva 2019

This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (http://creativecommons.org/licenses/by/4.0/) You are free to copy, distribute and transmit the work, provided the original author and source are credited.

This article is available from https://www.excli.de/vol18/Gonzalez_Leiva_22012019_proof.pdf


Recently Sara Crespo Yanguas and colleagues from the University of Brussel published a study about the role of pannexin1 in the pathogenesis of liver fibrosis (Crespo Yanguas et al., 2018[3]). Panx channels are known as mediators of ATP release (Dahl, 2015[4]). After injury cells may release ATP and uridine-5'-triphosphate into the extracellular space. The released ATP attracts immune cells to the area of damage (Davalos et al., 2005[5]; Chekeni et al., 2010[2]). In cardiac fibrosis cardiomyocytes have been shown to release ATP via pannexin1 which contributes to activation of fibroblasts (Dolmatova et al., 2012[6]). However, in liver the role of pannexin1 in liver fibrosis remains unknown. Therefore, the authors compared pannexin1 knockout and wild-type mice after CCl4 treatment for 8 weeks and after bile duct ligation (Crespo Yanguas et al., 2018[3]).

Interestingly, pannexin1 knockout mice showed reduced collagen content, stellate cell activation, and inflammation compared to wild-type mice. Therefore, the release of ATP seems to contribute to myofibroblast activation also in the liver. In contrast to the CCl4- fibrosis model, bile duct ligation led to more hepatocellular injury and a stronger immune response in the pannexin1 knockout than in wild-type mice.

It is not surprising that different consequences are observed in the CCl4 and the bile duct ligation models. CCl4 is a model of pericentral liver damage where a fraction of approximately 40 % of hepatocytes in the centre of the lobule are killed (Hoehme et al., 2010[16]; Hammad et al., 2017[14]; Bartl et al., 2015[1]). It seems plausible that the ATP released from these damaged hepatocytes activates stellate cells (Leist et al., 2017[18]). In contrast, bile duct ligation leads to a ductular response with proliferation of cholangiocytes, branching and looping of bile ducts, leading to a denser mesh of interlobular bile ducts around portal veins (Vartak et al., 2016[21]; Jansen et al., 2017[17]). Simultaneously, periportal fibrosis occurs (Ghallab et al., 2018[10]). It is interesting that this phenomenon is enhanced by the pannexin1 knockout, although the responsible mechanism still has to be elucidated.

Currently, hepatotoxicity in vivo (Stöber, 2016[20]; Du et al., 2017[7]; Reif et al., 2017[19]; Hammad et al., 2018[15]; Ghallab et al., 2016[9]) as well as mechanistic studies in hepatocyte in vitro systems represent very active research areas (Ghallab, 2017[8]; Godoy et al., 2013[11], 2015[12], 2016[13]). In this rapidly progressing field Sara Crespo Yanguas and colleagues made an important contribution by revealing the role of ATP-release channels in the pathogenesis of liver fibrosis.

Bartl M Pfaff M Ghallab A Driesch D Henkel SG Hengstler JG Optimality in the zonation of ammonia detoxification in rodent liver Arch Toxicol 2015 89 2069 2078 Chekeni FB Elliott MR Sandilos JK Walk SF Kinchen JM Lazarowski ER Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis Nature 2010 467 7317 863 867 Crespo Yanguas S da Silva TC Pereira IVA Maes M Willebrords J Shestopalov VI Genetic ablation of pannexin1 counteracts liver fibrosis in a chemical, but not in a surgical mouse model Arch Toxicol 2018 92 2607 2627 Dahl G ATP release through pannexon channels Philos Trans R Soc Lond B Biol Sci 2015 370 1672. Davalos D Grutzendler J Yang G Kim JV Zuo Y Jung S . ATP mediates rapid microglial response to local brain injury in vivo Nat Neurosci 2005 8 752 758 Dolmatova E Spagnol G Boassa D Baum JR Keith K Ambrosi C Cardiomyocyte ATP release through pannexin 1 aids in early fibroblast activation Am J Physiol Heart Circ Physiol 2012 303 H1208 H1218 Du K Farhood A Jaeschke H Mitochondria-targeted antioxidant Mito-Tempo protects against acetaminophen hepatotoxicity Arch Toxicol 2017 91 761 773 Ghallab A Highlight report: Metabolomics in hepatotoxicity testing EXCLI J 2017 16 1323 1325 Ghallab A Cellière G Henkel SG Driesch D Hoehme S Hofmann U Model-guided identification of a therapeutic strategy to reduce hyperammonemia in liver diseases J Hepatol 2016 64 860 871 Ghallab A Hofmann U Sezgin S Vartak N Hassan R Zaza A Bile micro-infarcts in cholestasis are initiated by rupture of the apical hepatocyte membrane and cause shunting of bile to sinusoidal blood Hepatology 13 Aug 2018 Epub ahead of print 10.1002/hep.30213. Available from: http://dx.doi.org/10.1002/hep.30213 Godoy P Hewitt NJ Albrecht U Andersen ME Ansari N Bhattacharya S Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME Arch Toxicol 2013 87 1315 1530 Godoy P Schmidt-Heck W Natarajan K Lucendo-Villarin B Szkolnicka D Asplund A Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells J Hepatol 2015 63 934 942 Godoy P Widera A Schmidt-Heck W Campos G Meyer C Cadenas C Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue Arch Toxicol 2016 90 2513 2529 Hammad S Braeuning A Meyer C Mohamed FEZA Hengstler JG Dooley S A frequent misinterpretation in current research on liver fibrosis: the vessel in the center of CCl4-induced pseudolobules is a portal vein Arch Toxicol 2017 91 3689 3692 Hammad S Ellethy T Othman A Mahmoud HYAH Highlight report: hepatotoxicity prediction with Hep3B cells Arch Toxicol 2018 92 2403 Hoehme S Brulport M Bauer A Bedawy E Schormann W Hermes M Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regeneration Proc Natl Acad Sci U S A 2010 107 10371 10376 Jansen PL Ghallab A Vartak N Reif R Schaap FG Hampe J The ascending pathophysiology of cholestatic liver disease Hepatology 2017 65 722 738 Leist M Ghallab A Graepel R Marchan R Hassan R Bennekou SH Adverse outcome pathways: opportunities, limitations and open questions Arch Toxicol 2017 91 3477 3505 Reif R Ghallab A Beattie L Günther G Kuepfer L Kaye PM In vivo imaging of systemic transport and elimination of xenobiotics and endogenous mol-ecules in mice Arch Toxicol 2017 91 1335 1352 Stöber R Pathophysiology of cholestatic liver disease and its relevance for in vitro tests of hepatotoxicity EXCLI J 2016 15 870 871 Vartak N Damle-Vartak A Richter B Dirsch O Dahmen U Hammad S Cholestasis-induced adaptive remodeling of interlobular bile ducts Hepatology 2016 63 951 964